Cargando…
Ivermectin as a potential treatment for COVID-19?
Autores principales: | Chosidow, Olivier, Bernigaud, Charlotte, Guillemot, Didier, Giraudeau, Bruno, Lespine, Anne, Changeux, Jean-Pierre, Bourhy, Hervé, Lecuit, Marc, Amoura, Zahir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168910/ https://www.ncbi.nlm.nih.gov/pubmed/34061842 http://dx.doi.org/10.1371/journal.pntd.0009446 |
Ejemplares similares
-
Bénéfice de l’ivermectine : de la gale à la COVID-19, un exemple de sérendipité
por: Bernigaud, C., et al.
Publicado: (2020) -
Human Dominant Disease Genes Are Enriched in Paralogs Originating from Whole Genome Duplication
por: Singh, Param Priya, et al.
Publicado: (2014) -
High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug
por: Chosidow, Olivier, et al.
Publicado: (2018) -
Response to: Comment on Rohrscheib et al. 2016 "Intensity of mutualism breakdown is determined by temperature not amplification of Wolbachia genes"
por: Rohrscheib, Chelsie E., et al.
Publicado: (2017) -
HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads
por: Hayes, Richard, et al.
Publicado: (2015)